Clinical Trial Update: Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls

View source ↗

Summary

This clinical trial update presents extended follow-up data from a Costa Rica study of an HPV-16/18 vaccine in young women. It compares vaccinated participants …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Cervical Cancer
• Hpv-related Cervical Cancer
• Human Papillomavirus Infection
• Oral Cavity Cancer

Drugs mentioned

• HPV-16/18 vaccine (Cervarix)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Anal Carcinoma, Cervical Carcinoma | Status: ACTIVE_NOT_RECRUITING